Illumina (ILMN) Convertible Debt (2011 - 2022)

Illumina (ILMN) posted Convertible Debt of $746.0 million for Q2 2022, up 6.27% quarter-over-quarter from $702.0 million in Q1 2022, and up 9.71% year-on-year from $680.0 million in Q2 2021.

Illumina (ILMN) Convertible Debt (2011 - 2022) Analysis & Trends

Illumina (ILMN) has reported Convertible Debt for 7 consecutive years, with $746.0 million the latest figure, recorded in Q2 2022.

  • Convertible Debt for Q2 2022 came in at $746.0 million, up 9.71% year-over-year; the trailing twelve-month figure through Apr 2022 was $746.0 million (up 9.71% YoY), and the FY2022 annual result was $702.0 million, up 4.31% from the prior year.
  • Convertible Debt was $746.0 million for Q2 2022 at Illumina, up from $702.0 million in the prior quarter.
  • Over five years, Convertible Debt peaked at $746.0 million in Q2 2022 and troughed at $673.0 million in Q1 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn
10 Quest Diagnostics 23.76 Bn 23.67 Bn 942.00 Mn

Historic Data

Download Data
DateValue
Apr 3, 2022 746.00 Mn
Jan 2, 2022 702.00 Mn
Oct 3, 2021 694.00 Mn
Jul 4, 2021 687.00 Mn
Apr 4, 2021 680.00 Mn
Jan 3, 2021 673.00 Mn
Jun 28, 2015 1.00 Bn
Mar 29, 2015 993.78 Mn
Dec 28, 2014 986.78 Mn
Sep 28, 2014 979.84 Mn
Jun 29, 2014 972.95 Mn
Dec 29, 2013 839.31 Mn
Sep 29, 2013 830.69 Mn
Jun 30, 2013 822.17 Mn
Mar 31, 2013 813.74 Mn
Dec 30, 2012 805.41 Mn
Sep 30, 2012 797.16 Mn
Jul 1, 2012 789.01 Mn
Apr 1, 2012 780.94 Mn
Jan 1, 2012 807.37 Mn